Halozyme Therapeutics, Inc.
US ˙ NasdaqGS ˙ US40637H1095

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for LaBarre Michael J.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at LaBarre Michael J. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:HALO / Halozyme Therapeutics, Inc. SVP, CHIEF TECHNICAL OFFICER 173.756
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af LaBarre Michael J.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb HALO / Halozyme Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i HALO / Halozyme Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Insidersalg HALO / Halozyme Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i HALO / Halozyme Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-02-16 HALO LaBarre Michael J. 2.878 49,2600 2.878 49,2600 141.770 81 30.2800 -54.624 -38,53

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af LaBarre Michael J. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-02-27 2025-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -100 173.756 -0,06 58,74 -5.874 10.206.427
2025-02-27 2025-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1.597 173.856 -0,91 58,25 -93.028 10.127.460
2025-02-27 2025-02-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -600 175.453 -0,34 58,65 -35.189 10.289.968
2025-02-27 2025-02-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.400 176.053 -5,07 58,09 -546.055 10.227.095
2025-02-27 2025-02-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -700 185.453 -0,38 58,67 -41.069 10.880.528
2025-02-27 2025-02-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.300 186.153 -4,76 58,01 -539.465 10.798.177
2025-02-24 2025-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.410 195.453 -1,22 57,75 -139.178 11.287.411
2025-02-24 2025-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4.747 197.863 2,46
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.164 193.116 -1,11 58,29 -126.140 11.256.732
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4.263 195.280 2,23
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3.103 191.017 -1,60 58,29 -180.874 11.134.381
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6.112 194.120 3,25
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -8.721 188.008 -4,43 58,29 -508.347 10.958.986
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 20.891 196.729 11,88
2025-02-18 2025-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1.304 175.838 -0,74 58,29 -76.010 10.249.597
2025-02-18 2025-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3.386 177.142 1,95
2024-10-16 2024-10-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 173.756 -5,44 53,26 -532.590 9.254.071
2024-10-16 2024-10-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 183.756 5,76 19,98 199.800 3.671.445
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -77 173.756 -0,04 54,24 -4.177 9.425.394
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.923 173.833 -5,40 53,74 -533.292 9.342.307
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 4.491 183.756 2,51 19,98 89.730 3.671.445
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 5.509 179.265 3,17 16,65 91.725 2.984.762
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2.037 173.756 -1,16 62,58 -127.477 10.873.824
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7.963 175.793 -4,33 61,89 -492.838 10.880.005
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 183.756 5,76 16,65 166.500 3.059.537
2024-09-18 2024-09-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 173.756 -5,44 62,88 -628.780 10.925.430
2024-09-18 2024-09-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 183.756 5,76 16,65 166.500 3.059.537
2024-08-27 2024-08-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5.580 173.756 3,32 18,41 102.728 3.198.848
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -100 168.176 -0,06 62,34 -6.234 10.484.092
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.900 168.276 -5,56 61,74 -611.236 10.389.529
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 16,65 166.500 2.966.630
2024-08-21 2024-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 168.176 -5,61 61,06 -610.550 10.267.986
2024-08-21 2024-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 16,65 166.500 2.966.630
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 168.176 -5,61 55,12 -551.150 9.269.020
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8.285 178.176 4,88 16,65 137.945 2.966.630
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1.715 169.891 1,02 8,11 13.909 1.377.816
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5.291 168.176 -3,05 55,26 -292.407 9.294.247
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4.709 173.467 -2,64 54,46 -256.466 9.447.533
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 8,11 81.100 1.445.007
2024-06-20 2024-06-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 168.176 -5,61 49,43 -494.260 8.312.267
2024-06-20 2024-06-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 8,11 81.100 1.445.007
2024-05-22 2024-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 168.176 -5,61 45,38 -453.840 7.632.500
2024-05-22 2024-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 8,11 81.100 1.445.007
2024-05-22 2024-05-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 168.176 -5,61 45,16 -451.640 7.595.501
2024-05-22 2024-05-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 8,11 81.100 1.445.007
2024-04-17 2024-04-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 168.176 -5,61 38,49 -384.890 6.472.926
2024-04-17 2024-04-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 8,11 81.100 1.445.007
2024-04-17 2024-04-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 168.176 -5,61 38,35 -383.500 6.449.550
2024-04-17 2024-04-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 178.176 5,95 8,11 81.100 1.445.007
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 2.890 168.176 1,75 8,11 23.438 1.363.907
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 292 165.286 0,18 16,78 4.900 2.773.499
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.436 164.994 5,39 12,07 101.823 1.991.478
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 156.558 -6,00 42,27 -422.730 6.618.176
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 3.551 166.558 2,18 8,11 28.799 1.350.785
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 6.449 163.007 4,12 12,07 77.839 1.967.494
2024-03-13 2024-03-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 156.558 -6,00 41,64 -416.370 6.518.605
2024-03-13 2024-03-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 166.558 6,39 12,07 120.700 2.010.355
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7.471 156.558 -4,55 39,54 -295.418 6.190.616
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 7.471 164.029 4,77 8,11 60.590 1.330.275
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2.529 156.558 -1,59 39,56 -100.045 6.193.278
2024-02-28 2024-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 159.087 -5,91 39,95 -399.460 6.354.889
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.160 169.087 -1,26 36,10 -77.976 6.104.041
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4.264 171.247 2,55
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3.097 166.983 -1,82 36,10 -111.802 6.028.086
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6.112 170.080 3,73
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3.832 163.968 -2,28 35,91 -137.607 5.888.091
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
A - Award 8.479 167.800 5,32
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1.208 159.321 -0,75 35,91 -43.379 5.721.217
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3.386 160.529 2,15
2024-02-13 2024-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.901 157.143 -1,81 35,49 -102.956 5.577.005
2024-02-13 2024-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.133 160.044 5,35
2024-01-18 2024-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 151.911 -6,18 36,00 -360.000 5.468.796
2024-01-18 2024-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 161.911 6,58 12,07 120.700 1.954.266
2024-01-18 2024-01-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 151.911 -6,18 36,00 -360.000 5.468.796
2024-01-18 2024-01-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 161.911 6,58 12,07 120.700 1.954.266
2023-12-13 2023-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 151.911 -6,18 40,39 -403.940 6.136.293
2023-12-13 2023-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 161.911 6,58 12,07 120.700 1.954.266
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -643 151.911 -0,42 40,46 -26.019 6.147.079
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.357 152.554 -5,78 39,58 -370.303 6.037.325
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1.467 161.911 0,91 12,07 17.707 1.954.266
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8.533 160.444 5,62 13,81 117.841 2.215.732
2023-11-16 2023-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 151.911 -6,18 39,79 -397.880 6.044.235
2023-11-16 2023-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 161.911 6,58 13,81 138.100 2.235.991
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1.708 151.911 -1,11 39,08 -66.747 5.936.530
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1.708 153.619 1,12 16,78 28.660 2.577.727
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8.292 151.911 -5,18 39,08 -324.043 5.936.530
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8.292 160.203 5,46 13,81 114.513 2.212.403
2023-10-17 2023-10-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 151.911 -6,18 36,52 -365.200 5.547.790
2023-10-17 2023-10-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 161.911 6,58 19,98 199.800 3.234.982
2023-09-19 2023-09-19 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 151.911 -6,18 39,10 -390.980 5.939.416
2023-09-19 2023-09-19 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 161.911 6,58 19,98 199.800 3.234.982
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8.075 151.911 -5,05 42,41 -342.437 6.442.090
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8.075 159.986 5,32 19,98 161.338 3.196.520
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1.925 151.911 -1,25 42,41 -81.633 6.442.090
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1.925 153.836 1,27 18,41 35.439 2.832.121
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 2.825 151.911 1,89 8,11 22.911 1.231.998
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7.175 149.086 5,06 13,81 99.087 2.058.878
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 141.911 -6,58 40,43 -404.300 5.737.462
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 151.911 7,05 18,41 184.100 2.796.682
2023-06-22 2023-06-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 141.911 -6,58 36,00 -360.000 5.108.796
2023-06-22 2023-06-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 151.911 7,05 18,41 184.100 2.796.682
2023-04-19 2023-02-27 4/A HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2.984 141.911 -2,06 49,55 -147.854 7.031.548
2023-04-19 2023-02-27 4/A HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 2.984 144.895 2,10 18,41 54.935 2.667.517
2023-04-19 2023-04-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 141.911 -6,58 36,00 -360.000 5.108.796
2023-04-19 2023-04-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10.000 151.911 7,05 18,41 184.100 2.796.682
2023-02-28 2023-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2.984 138.927 -2,10 49,55 -147.854 6.883.694
2023-02-28 2023-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7.016 141.911 -4,71 49,55 -347.629 7.031.406
2023-02-21 2023-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -2.878 148.927 -1,90 49,26 -141.770 7.336.144
2023-02-21 2023-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6.112 151.805 4,20
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1.170 145.693 -0,80 49,20 -57.564 7.168.096
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3.386 146.863 2,36
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10.000 143.477 -6,52 48,39 -483.940 6.943.426
2023-02-14 2023-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.725 153.477 -1,74 48,92 -133.307 7.508.095
2023-02-14 2023-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7.883 156.202 5,31
2023-02-14 2023-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.951 148.319 -1,95 48,92 -144.363 7.255.765
2023-02-14 2023-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.133 151.270 5,68
2023-01-18 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1.122 143.137 -0,78 50,93 -57.139 7.289.395
2023-01-18 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8.878 144.259 -5,80 50,40 -447.451 7.270.654
2022-12-13 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5.065 153.137 -3,20 58,66 -297.133 8.983.629
2022-12-13 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4.935 158.202 -3,03 58,67 -289.541 9.281.870
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3.115 163.137 -1,87 54,14 -168.643 8.832.074
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8 166.252 0,00 54,61 -437 9.079.022
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6.877 166.260 -3,97 54,12 -372.183 8.997.991
2022-02-17 2022-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 24.448 24.448
2022-02-17 2022-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 74.777 74.777
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -3.386 10.158 -25,00
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1.170 173.137 -0,67 34,43 -40.283 5.961.107
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3.386 174.307 1,98
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5.771 0 -100,00
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1.995 170.921 -1,15 33,64 -67.112 5.749.782
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5.771 172.916 3,45
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7.883 7.883 -50,00
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.725 167.145 -1,60 34,20 -93.195 5.716.359
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7.883 169.870 4,87
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8.133 16.266 -33,33
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.992 161.987 -1,81 34,94 -104.540 5.659.826
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.133 164.979 5,19
2021-10-12 2021-10-12 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -8.050 0 -100,00
2021-10-12 2021-10-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.050 156.846 5,41 13,10 105.455 2.054.683
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -29.450 8.050 -78,53
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -29.450 148.796 -16,52 39,93 -1.175.968 5.941.573
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 29.450 178.246 19,79 13,10 385.795 2.335.023
2021-07-15 2021-07-15 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -14.685 0 -100,00
2021-07-15 2021-07-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 14.685 148.796 10,95 6,55 96.187 974.614
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -40.315 14.685 -73,30
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -40.315 134.111 -23,11 45,70 -1.842.315 6.128.604
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 40.315 174.426 30,06 6,55 264.063 1.142.490
2021-05-03 2021-05-03 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -11.311 0 -100,00
2021-05-03 2021-05-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11.311 134.111 9,21 11,29 127.701 1.514.113
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -28.689 11.311 -71,72
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -18.994 122.800 -13,40 42,79 -812.829 5.255.103
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9.695 141.794 -6,40 42,10 -408.208 5.970.236
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 28.689 151.489 23,36 11,29 323.899 1.710.311
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6.530 122.800 -5,05 46,26 -302.061 5.680.409
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -11.794 129.330 -8,36 45,56 -537.303 5.891.926
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8.803 0 -100,00
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -4.364 141.124 -3,00 48,69 -212.483 6.871.328
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.803 145.488 6,44
2021-02-17 2021-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 13.544 13.544
2021-02-17 2021-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 23.311 23.311
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5.771 5.771 -50,00
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.272 136.685 -1,64 49,84 -113.236 6.812.380
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5.771 138.957 4,33
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7.883 15.766 -33,33
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.725 133.186 -2,00 49,84 -135.814 6.637.990
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7.883 135.911 6,16
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8.134 24.399 -25,00
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.906 128.028 -2,22 50,60 -147.044 6.478.217
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.134 130.934 6,62
2020-12-21 2020-12-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -600 122.800 -0,49 43,25 -25.951 5.311.346
2020-12-21 2020-12-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -11.400 123.400 -8,46 42,54 -484.967 5.249.559
2020-11-20 2020-11-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7.889 134.800 -5,53 39,04 -307.955 5.262.053
2020-11-20 2020-11-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4.111 142.689 -2,80 38,24 -157.221 5.456.998
2020-10-20 2020-10-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12.000 146.800 -7,56 30,43 -365.148 4.466.977
2020-09-21 2020-09-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12.000 158.800 -7,03 26,91 -322.884 4.272.832
2020-08-20 2020-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12.000 170.800 -6,56 28,30 -339.564 4.833.128
2020-07-20 2020-07-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12.000 182.800 -6,16 29,01 -348.072 5.302.297
2020-05-22 2020-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -18.613 0 -100,00
2020-05-22 2020-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 18.613 194.800 10,56 7,14 132.897 1.390.872
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -21.387 18.613 -53,47
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -21.387 176.187 -10,82 23,80 -509.075 4.193.779
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 21.387 197.574 12,14 7,14 152.703 1.410.678
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8.803 8.803 -50,00
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3.044 176.187 -1,70 21,83 -66.451 3.846.162
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8.803 179.231 5,17
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5.772 11.542 -33,34
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1.995 170.428 -1,16 21,10 -42.094 3.596.031
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5.772 172.423 3,46
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7.883 23.649 -25,00
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2.725 166.651 -1,61 20,00 -54.500 3.333.020
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7.883 169.376 4,88
2020-02-12 2020-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 32.533 32.533
2020-02-12 2020-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 69.174 69.174
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11.559 0 -100,00
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -4.289 161.493 -2,59 19,21 -82.392 3.102.281
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11.559 165.782 7,49
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308.446
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308.446
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308.446
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)